• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

LIVZON GROUP(000513.SZ)

Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec30
Lizhu Pharmaceutical Extends Equity Transfer Deadline for Acquisition of Vietnamese Listed Company Imexpharm Corporation to June 30, 2026
14:14
Lizhu Pharmaceutical Plans Public Tender Offer to Acquire Shares of Imexpharm Corporation
13:02
Dec24
Lizhu Pharmaceutical and XinKangHe BioMed's Lekangqita Injection Receives NMPA Marketing Authorization Application Acceptance
09:36
Dec21
Lizhu Pharmaceutical Factory Obtains Approval for NS-041 Tablet's New Clinical Trial for Depression
07:53
Dec3
Lizhu Pharmaceutical Donates 10 Million HKD to Support Victims of Hong Kong Fire
02:40
Nov7
Lizhu Pharmaceutical repurchased 160,100 A-shares
09:56

Schedules & Filings

Schedules
Filings
Oct23
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 2.844 B, Net Income 473.01 M, EPS 0.5295

Aug20
Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 3.091 B, Net Income 644.38 M, EPS 0.7197

Jun13
Distribution Plan(CST)

Cash dividend 1.1 CNY

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More